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INTRODUCTION
Recent evidence demonstrating extensive crosstalk among the nervous, immune, and circulatory systems has sparked exciting research studying their interactions. Specifically, it has been shown that immune cells and molecules can cross the bloodbrain barrier (BBB) under both physiological and pathological conditions (Becher et al., 2017; Klein et al., 2017; Prinz and Priller, 2017; Zhao et al., 2015) . Furthermore, a number of classic immune molecules, including cytokines and cell surface molecules, have newly identified functions in neural development and plasticity (Boulanger, 2009; Deverman and Patterson, 2009; Estes and McAllister, 2015; Shatz, 2009 ). Finally, cells of the nervous and immune systems have been shown to bidirectionally regulate each other (Becher et al., 2017; Dantzer et al., 2008; Klein et al., 2017; Wohleb et al., 2016) .
The response to infection is a physiopathological condition under which crosstalk among the three systems is of particular relevance. Young children are especially vulnerable, with infection being a leading cause of mortality for children under 5 years of age (Liu et al., 2015) . If not timely and effectively treated, systemic infection can lead to central nervous system (CNS) inflammation, resulting in encephalitis, meningitis, seizures, and sometimes coma. Long-term adverse consequences of neonatal neuroinflammation, partly attributed to excessive immune responses to systemic infection, include intellectual disability, epilepsy, autism spectrum disorder, and schizophrenia (Chandran et al., 2011; McAllister, 2015, 2016; Klein et al., 2017; Knuesel et al., 2014; Meyer et al., 2011; Vezzani et al., 2011; Xanthos and Sandk€ uhler, 2014) .
Previous studies have shown that microglia and astrocyte activation, as well as influx of monocytes into the brain parenchyma, together with the cytokines that they release, all contribute significantly to infection-induced neuroinflammation (Klein et al., 2017; Liddelow and Barres, 2017; Priller, 2014, 2017; Salter and Stevens, 2017; Sofroniew, 2015) . However, since previous studies mostly focused on the long-term effects of neuroinflammation, the early events are less well characterized. In particular, it is unknown whether a specific cell type functions as the sensor of system infection in the brain. Furthermore, it is also unknown whether specific molecule(s) released by this cell type(s) relay and/or broadcast the inflammatory signal to other cells in the brain. If such cells and signals exist, a better understanding of their mechanism and time course of action could provide a way to rapidly and effectively dampen excessive immune response during inflammation. New and effective ways to balance sufficient immune response to eliminate the external insult, while not damaging self, are key to more effective treatment and better prognosis.
Here we showed that the cell type first activated in the CNS in response to systemic inflammation is the PDGFRb cell, the mural cell of blood vessels. By single-cell RNA sequencing (RNA-seq), we showed that Col1a1 and Rgs5 subgroups of PDGFRb cells are the main source of CCL2. Within 2 hr of inducing systemic inflammation, PDGFRb cells secreted CC chemokine ligand 2 (CCL2, also known as monocyte chemotactic protein-1, MCP1), which in turn increased total neuronal excitability by promoting excitatory synaptic transmission in glutamatergic neurons of multiple brain regions. Importantly, when Ccl2 was conditionally knocked out from PDGFRb cells, the effect of LPS-induced increase in excitatory synaptic transmission was significantly attenuated. Together, these results provide in vivo demonstration that Col1a1 and Rgs5 subgroups of PDGFRb cells function as initial sensors to external insults by secreting CCL2, which subsequently relays the inflammatory signal to the CNS.
RESULTS

Astrocytes and Microglia Are Not the Main Sources of CCL2 during Early Neuroinflammation
To examine the early effects of systemic inflammation, we intraperitoneally (i.p.) injected postnatal day 14 (P14) mice with varying doses of agents commonly used to mimic infection by bacteria and/or viruses, including lipopolysaccharides (LPS), double-stranded RNA (dsRNA; Poly(I:C)), or CpG DNA (ODN 1668) , to stimulate Toll-like receptor TLR4, TLR3, or TLR9 pathways (Kawai and Akira, 2010) , respectively. Hippocampal mRNA levels of proinflammatory cytokines and chemokines previously reported to mediate responses to inflammation in the brain (Breder et al., 1994; Erickson and Banks, 2011; Nadeau and Rivest, 1999; Quan et al., 1998b; Thibeault et al., 2001; Valliè res and Rivest, 1997) , including Ccl2, tumor necrosis factor a (Tnfa), interleukin 1b (Il1b), and Il6, were significantly elevated 2 hr following injections ( Figure S1 ). Since the effect of all cytokines maxed out at 10 mg/kg, we used this dose to examine the time course of responses. All agents elevated mRNA and protein expression of the cytokines, with variability in the extent of change and in the time course ( Figure S2 ). Of the cytokines examined, Ccl2 mRNA and CCL2 protein showed the highest fold change in response to stimulation by all three agents (Figure S2) . In absolute quantitation, 2 hr following stimulation by each of three agents, Ccl2 mRNA copy number and CCL2 protein concentration were both the highest ( Figures 1A and 1B ). The consistent increase in CCL2 level across multiple systemic inflammation models suggest that it may be a key signaling molecule in the brain during the inflammatory process. Since we are most interested in early responses, for the remainder of this study, we focused on the 2 hr time point and used 10 mg/kg of LPS or Poly(I:C).
We confirmed, using in situ hybridization, that the Ccl2 mRNA level was significantly elevated in the brain of P14 mice 2 hr after LPS injection ( Figures S3A-S3C ). Using a knockin mouse line expressing RFP under the endogenous Ccl2 promoter (Ccl2-RFP flox ), we further showed that CCL2 protein (CCL2-2A-RFP) was also highly expressed 2 hr following LPS injection and colocalized with Ccl2 mRNA (Figures 1C, S3D, and S3E; 45.56% ± 4.50% colocalization with respect to [w.r.t.] total mRNA, 44.49% ± 7.74% w.r.t. total RFP).
The in situ results also provided spatial information for identifying the cell type that expressed Ccl2. Since astrocyte and microglia activation during neuroinflammation is well documented (Liddelow and Barres, 2017; Prinz and Priller, 2014; Salter and Stevens, 2017; Sofroniew, 2015) , we first examined colocalization between Ccl2 mRNA and the microglia marker ionized calcium binding adaptor molecule 1 (Iba1) or the astrocyte marker glial fibrillary acidic protein (GFAP) 2 hr following either LPS or Poly(I:C) injection. To our surprise, colocalization, defined as overlap between the two signals at the pixel level, was low for either marker (LPS: GFAP, 11.03% ± 0.84%, Iba1, 15.27% ± 6.26%; Poly(I:C): GFAP, 9.86% ± 1.36%, Iba1, 21.76% ± 2.12%; Figures 1D-1Q ). To aid visualization, we also plotted fluorescence intensity of Ccl2 mRNA and Iba1/GFAP immunostaining along indicated lines. The plots clearly showed that while Ccl2 and Iba1/GFAP signals are often juxtaposed, they mostly did not colocalize. Consistently, we only observed significant increase in GFAP or Iba1 immunostaining 24 hr following LPS injection and no obvious astrogliosis or microgliopathy at the earlier 2 hr or 6 hr time points ( Figure S4 ). Thus, astrocytes and microglia are unlikely to be the main source of CCL2 during early neuroinflammation.
PDGFRb Cells, Not Endothelial Cells, Express CCL2 during the Initial Phase of Neuroinflammation Our in situ hybridization results showed a high Ccl2 level surrounding the meninges ( Figure S3A ) and blood vessels (Figure S3B) . A previous study reported elevated Ccl2 following LPS injection in regions including these. Based on colocalization between radioactively labeled Ccl2 in situ probe and immunostaining for an endothelial cell marker, endothelial cells were thought to be the source of CCL2 (Thibeault et al., 2001) . However, we observed relatively little colocalization between Ccl2 and the endothelial cell marker Glut1, even though sometimes Ccl2and Glut1-positive cells were juxtaposed (LPS: 12.82% ± 1.36%; Poly(I:C): 7.75% ± 3.17%; Figures 2A-2C , 2G-2I, 2M, and 2N). Much higher colocalization-close to 50%-was observed between Ccl2 and platelet-derived growth factor receptor b (PDGFRb) (LPS: 46.91% ± 3.76%; Poly(I:C): 49.51% ± 2.87%; Figures 2D-2F and 2J-2N). PDGFRb cells, the mural cells of blood vessels, are located along intervals within the vascular basement membrane. Given the physical proximity between mural cells and endothelial cells and the resolution limit of autoradiography (Thibeault et al., 2001) , our data are not inconsistent with previous reports.
To confirm Ccl2 expression in PDGFRb cells, we performed in situ hybridization using Pdgfrb-Cre;Ai9 mice (Cuttler et al., 2011) , previously shown to label mural cells in the brain (Hartmann et al., 2015; Jung et al., 2018) . Ccl2 mRNA colocalized with Pdgfrb-Cre;Ai9 at the meninges and around blood vessels ( Figure 2O ). High-level colocalization was also found between CCL2-2A-RFP and PDGFRb antibody ( Figure 2P ; 52.38% ± 8.45% w.r.t. RFP). PDGFRb antibody staining also highly colocalized with RFP in Pdgfrb-Cre;Ai9 mice ( Figure S3F ; 69.42% ± 6.67% w.r.t. Pdgfb-Cre;Ai9 and 74.60% ± 1.03% w.r.t. PDGFRb antibody), consistent with previous reports (Cuttler et al., 2011; Hartmann et al., 2015) and further confirming specificity of Pdgfrb-Cre in labeling mural cells.
Rgs5 and Col1a1 Subtypes of PDGFRb Cells Express Ccl2
Mural cells mostly comprise pericytes and vascular smooth muscle cells (Armulik et al., 2011; Hartmann et al., 2015; Jung et al., 2018) . Pericytes align blood microvessels, are located along intervals within the vascular basement membrane, and have been shown to be critical for maintaining the BBB's integrity (Armulik et al., 2010 (Armulik et al., , 2011 Bell et al., 2010; Daneman et al., 2010; Rustenhoven et al., 2017; Sweeney et al., 2016) . Vascular smooth muscle cells form relatively continuous cell layers around arteries and veins and regulate blood vascular tone and vessel diameter, blood pressure, and flow (Gaengel et al., 2009) . Do both cell types secrete Ccl2? Are there other perivascular cells that also secrete Ccl2? To further characterize these cells, we dissociated the hippocampi of P14 mice 2 hr following LPS or saline (Ctrl) injection and performed single-cell RNA-seq, using previously described methods (Zeisel et al., 2015) . Single cells were captured on the 10X Chromium instrument. From three independent experiments, we obtained 9,957 cells for the Ctrl group and 9,675 cells for the LPS group after quality control. The batch effect was regressed out using Seurat (Satija Figure S3 . et al., 2015) . LPS and Ctrl groups were aligned and combined using Seurat (Butler et al., 2018) ( Figure 3A ). Unsupervised clustering and t-distributed stochastic neighbor embedding (tSNE) plot were used to characterize and visualize transcriptional heterogeneity among all cells (see STAR Methods for details). Nineteen clusters were identified ( Figure 3B ) and named according to commonly use cell-type names or, where unclear, the most significant marker gene of the cluster. Cells were assigned to clusters based on sharing a group of specifically expressed genes.
Consistent with in situ results, Ccl2 expression was highly similar to that of reported pericyte markers, including Pdgfrb, Vtn, Ifitm1, Foxc1, Tbx18, Rgs5, Kcnj8, Abcc9, and Col1a1 (Figure 3C) (Armulik et al., 2011; Vanlandewijck et al., 2018) . Ccl2 cells did not express the smooth muscle cell marker Acta2 (Figure 3C) . Myeloid cells (microglia or perivascular macrophages) (Ajami et al., 2018; Mrdjen et al., 2018) are key players of neuroinflammation in the CNS. However, Ccl2 was not significantly induced in cells expressing microglia markers (Iba1/Aif1) or perivascular macrophages markers (Cd163, Cd206/Mrc1) (Figures 3C and 3D) . Expression of Ccl2 in both Ctrl and LPS groups could be due to dissection-induced damage (Saijo and Glass, 2011) , as we did not observe high-level colocalization between Ccl2 and Iba1 ( Figure 1 ). Ccl2 expression was not detected in lymphatic vessel endothelial cells (Lyve1) or endothelial cells (Pecam1) ( Figure 3C ).
Analysis of Ccl2 expression according to the 19 identified cell clusters showed high expression in Col1a1 cells, microglia, Rgs5 cells, and astrocytes ( Figure S5A ). Ccl2 expression was similarly high in microglia in Ctrl and LPS samples (Figures 3D and 3E) , while its LPS-induced expression in astrocytes was much lower than that of Rgs5 and Col1a1 cells ( Figure 3D ). Ccl2 was the most significantly induced gene in Col1a1 cells and ranked within the top ten genes in Rgs5 cells (Table S1 ). What are Col1a1 and Rgs5 cells? The top ten marker genes in Col1a1 cells (Ctrl 176 cells; LPS 219 cells) are Col1a1, Col1a2, Dcn, Col3a1, Cp, Ifitm1, Nupr1, Cyp1b1, Lum, and Pcolce (Table S1 ). Col1a1 cells were previously identified as a subtype of Pdgfrb cells by single-cell RNA-seq (Bifari et al., 2017) . A recent report identified Col1a1 as a marker of perivascular fibroblast-like cells (Vanlandewijck et al., 2018) . These cells are in close association with arteries, arterioles, veins, and venules; are non-overlapping with endothelial cells and mural cells; and are located between the vessel wall and astrocytes endfeet (Vanlandewijck et al., 2018) . In addition to Col1a1, this cluster also shares the markers Col1a2, Dcn, Col3a1, and Lum with perivascular fibroblast-like cells (Vanlandewijck et al., 2018) . Col1a1 cells also express identified pericyte markers, including Pdgfrb, Vtn, Ifitm1, and Tbx18 ( Figure 3C ).
Rgs5 cells (Ctrl 265 cells; LPS 316 cells) are characterized by expression of Rgs5, Vtn, Myl9, Higd1, Ndufa4l2, Kcnj8, Sod3, Ebf1, Apold1, and Cox4i2. The top 50 markers (Table S1 ) include a number of identified pericyte markers, including Rgs5, Vtn, Kcnj8, Pdgfrb, Abcc9, and Tbx18 ( Figure 3C ). Thus, the Rgs5 cell cluster includes a significant proportion of cells classically identified as pericytes. We say ''include'' because a fraction of these cells (35.5% of Ctrl and 27.2% of LPS group) also express the vascular smooth muscle marker Acta2 ( Figure 3C ).
Together, our results identified Col1a1 cells as perivascular fibroblast-like cells and Rgs5 cells as a pericyte-including cell type. Since Vtn is expressed by both Rgs5 and Col1a1 cells and is a recently reported marker of Pdgfrb and NG2 double positive cells (He et al., 2016) , we examined colocalization of Vtn mRNA with CCL2-2A-RFP ( Figure 4A ) and with Pdgfrb-Cre;Ai9 ( Figures 4B and S5D ). The results showed high-level colocalization of Vtn with both markers.
In situ hybridization of Col1a1 and Ccl2, together with immunohistochemistry for PDGFRb, showed that Col1a1 colocalized well with both ( Figure 4C ). Consistent with previous characterization of perivascular fibroblast-like cells (Vanlandewijck et al., 2018) , Col1a1 cells are mainly located at meninges and large vessels. Ccl2-expressing and Col1a1-negative PDGFRb cells, most likely representing Rgs5-positive pericytes, are mainly located at small vessels ( Figure 4C ).
To further analyze Pdgfrb-expressing cells (defined as cells with equal/higher expression of Pdgfrb than the mean Pdgfrb expression in all cells), we performed unsupervised clustering of these cells by Seurat ( Figure S6A ). Col1a1 and Rgs5 cells remain the main sources of Ccl2 after LPS treatment. Rgs5 cells were further divvied into Rgs5(A) and Rgs5(B) cells. Rgs5(A) cells have high expression of pericyte markers Abcc9 and Kcnj8, while Rgs5(B) cells expressed the smooth muscle cell marker Acta2 ( Figure S6B ). A significant number of astrocytes also expressed Pdgfrb above the cutoff threshold for this analysis ( Figure S6A ), though their Pdgfrb expression was lower than that of other cell types ( Figure S6B ). Pdgfrb expression in astrocytes has been reported in previous single-cell RNA-seq studies (Zeisel et al., 2015; Zhang et al., 2014) . However, PDGFRb immunostaining or Ai9 expression in Pdgfrb-Cre;Ai9 mice was not observed in cells with classical astrocyte morphology in our samples and not previously reported. Ccl2 expression in Pdgfrb-expressing astrocytes was not significantly induced by LPS ( Figure S6B ).
In addition to Ccl2, a number of other cytokines and enzymes have previously been shown to be induced along blood vessels during acute infection, including Tnfa (Breder et al., 1994; Nadeau and Rivest, 1999) , Il6 (Valliè res and Rivest, 1997), Il1b (Ericsson et al., 1995; Nakamori et al., 1994; Quan et al., 1998b) , Pegs2 (Cao et al., 1995; Quan et al., 1998a) , Ptges (Ek et al., 2001) , and Cxcl10 (Blank et al., 2016) . In our dataset, (legend continued on next page) Tnfa was mainly expressed in microglia but at similar levels in Ctrl and LPS groups ( Figure 3E ). Il6 was also mostly expressed in PDGFRb cells but at a lower level than Ccl2. Cxcl10, Ptgs2/ Cox2, and Ptges were expressed in Col1a1 cells, Rgs5 cells, and endothelial cells.
PDGFRb Cells Are the Main Source of CCL2 during Early Neuroinflammation The single-cell RNA-seq results showed that the Col1a1 and Rgs5 subclasses of PDGFRb cells are the main sources of CCL2 during early inflammation. To assay this requirement functionally, we conditionally knocked out Ccl2 from PDGFRb cells in Pdgfrb-Cre;Ccl2 fl/fl mice. LPS-induced increase in hippocampal Ccl2 mRNA and CCL2 protein expression was significantly attenuated at 2 hr ( Figures 4D and 4E ), suggesting that PDGFRb cells are the main source of CCL2 during early neuroinflammation. In contrast, when Ccl2 was conditionally knocked out from endothelial cells in Tie2-Cre;Ccl2 fl/fl mice, hippocampal Ccl2 was not significantly affected ( Figures 4D and 4E) . These results provide important in vivo evidence that PDGFRb cells, but not endothelial cells, are the main source of CCL2 during early neuroinflammation. LPS-induced CCL2 was also detected in the cerebral spinal fluid (CSF) at 2 hr ( Figure 4F ). High CSF CCL2 during early systemic inflammation allows it to rapidly reach many regions in the brain and mediate downstream effects. Importantly, conditional knockout of Ccl2 from PDGFRb cells significantly attenuated this effect ( Figure 4F ), demonstrating a critical contribution of these cells to CSF CCL2 level.
A salient response to infection is sickness behavior (Dantzer et al., 2008; Wohleb et al., 2016) , comprising lethargy, social withdrawal, and other changes that decrease energy expenditure, with the likely function of promoting survival and/or not passing the infection to other individuals in the group. Previous reports showed that LPS-injected mice were less mobile in the tail-suspension test (Dantzer et al., 2008) . Here we showed that 2 hr after LPS injection, LPS-induced reduction in mobility was significantly attenuated in Pdgfrb-Cre;Ccl2 fl/fl mice to a level similar to control, non-LPS-injected mice ( Figure 4G ). These results suggest that CCL2 secretion by PDGFRb cells during the early phase of inflammation may have important physiological functions.
CCL2 Rapidly Increases Excitatory Synaptic Transmission
Having identified PDGFRb cells as initial responders during early neuroinflammation and CCL2 as their main signaling molecule, we next asked what cells CCL2 target. We recorded AMPAtype glutamate-receptor-mediated miniature excitatory postsynaptic currents (mEPSCs) from hippocampal CA1 pyramidal neurons in acute brain slices of P14 mice 2 hr after i.p. injection of LPS or Poly(I:C). The frequency of mEPSC was significantly increased, while its amplitude was not significantly affected ( Figures 5A , 5B, S7A, and S7B). Perfusion of CCL2 (100 ng/mL) (Gao et al., 2009; Gosselin et al., 2005) onto CA1 pyramidal neurons had similar effects, significantly increasing mEPSC frequency over the course of minutes ( Figures 5E and 5F ). Simplistically, mEPSC amplitude correlates with the density/conductance of postsynaptic receptors at individual synapses, while mEPSC frequency reflects the number of functional synapses and/or release probability of individual synapses. Both changes can have pre-and postsynaptic origins. For instance, an increase in mEPSC frequency could be due to unsilencing of ''silent'' synapses that contain NMDA receptors but lack AMPA receptors (Malenka and Nicoll, 1997) . Both mEPSC frequency and amplitude contribute to the total synaptic strength of the neuron, which can be measured as total charge transfer per second. CCL2 application significantly increased total synaptic charge ( Figure 5I ).
To further examine whether CCL2 application increased the total synaptic strength of synchronized release, we measured evoked EPSC following minimal stimulation of nearby stratum radiatum. CCL2 application significantly increased the amplitude of the evoked AMPA EPSC ( Figures 5J and 5K ). CCL2 application also increased the AMPA/NMDA ratio, a measure of the size of the evoked AMPA current, as a ratio of the NMDA current, suggesting a primarily postsynaptic effect through unsilencing of ''silent'' synapses ( Figures 5L and 5M ). Paired-pulse ratio (PPR), a measure of presynaptic release probability, was not affected ( Figures 5N and 5O ). Inhibitory synaptic transmission, measured as the frequency and amplitude of miniature inhibitory postsynaptic currents (mIPSC), also was not significantly affected (Figures S7C and S7D) .
Do these synaptic changes affect neuronal firing? Because spontaneous firing is very low in CA1 pyramidal neurons, we measured neuronal firing in response to step depolarizing current injections. Both LPS injection and CCL2 perfusion onto hippocampal slices increased total neuronal excitability ( Figures  5C, 5D , 5G, and 5H), which has contributions from excitatory and inhibitory synaptic inputs, as well as the neuron's intrinsic electrical properties. Consistent with the observed increase in excitatory synaptic transmission and lack of change in inhibitory synaptic transmission ( Figures 5E, 5F , S7C, and S7D), the effects of CCL2 were blocked by the AMPA receptor inhibitor NBQX, but not the GABA A receptor inhibitor gabazine ( Figures S7E-S7H ). CCL2 did not significantly affect intrinsic excitability ( Figures  S7I and S7J) .
Together, the above results demonstrate that CCL2 primarily affects CA1 pyramidal neurons by upregulating their excitatory synaptic transmission. CCL2 application onto hippocampal CA3 pyramidal neurons, dentate gyrus granule cells, or layer 2/3 pyramidal neurons of the primary somatosensory cortex ( Figures  5P-5AA ) all enhanced excitatory synaptic transmission and total neuronal excitability, suggesting a global effect of this molecule in regulating excitatory synaptic transmission in the brain.
The effect of CCL2 is mediated through CC chemokine receptor 2 (CCR2), its predominant receptor (Ré aux-Le Goazigo et al., 2013; Zlotnik and Yoshie, 2012) , as CCL2 application onto brain slices from Ccr2 knockout mice did not affect mEPSC frequency or total neuronal excitability ( Figures 6A-6D ). CCR2 expression has been described in neurons of the cerebral cortex and hippocampus (Ré aux-Le Goazigo et al., 2013) . When the level of CCR2 was specifically reduced in hippocampal pyramidal neurons using RNA interference (Ccr2 RNAi + ; Figure S7K for verification), CCL2-induced increase in mEPSC frequency was blocked (Figures 6E and 6F) , while that of neighboring uninfected neurons (Ccr2 RNAi À ) was not affected (Figures 6G and 6H) . Thus, postsynaptic and cell-autonomous expression of CCR2 is required for mediating the effect of CCL2. CCR2 is a G-protein-coupled receptor that, once activated, can lead to intracellular calcium release through phospholipase C (PLC) and inositol triphosphate signaling (Kuang et al., 1996) . Bath application of the PLC inhibitor U73122 (10 mM) or intracellular loading of the calcium chelator BAPTA (5 mM) into the postsynaptic cell both completely blocked the effect of CCL2 application on increasing mEPSC frequency ( Figures 6I-6L ). In addition to demonstrating the importance of calcium in mediating the effects of CCL2, this result provides further evidence that CCL2 mostly mediates its effects through postsynaptic mechanisms.
Pericyte-Secreted CCL2 Regulates Excitatory Synaptic Transmission and Total Neuronal Excitability
Could CCL2 secreted by PDGFRb cells regulate excitatory synaptic transmission? PDGFRb cells are mostly composed of pericytes and smooth muscle cells. When we stimulated primary cultures of human brain vascular pericytes (HBVPs) with 10 mg/mL LPS or Poly(I:C) for 1 to 4 hr, expression of CCL2, IL1b, and IL6 was significantly increased, with fold changes in CCL2 being the greatest (Figures S8A-S8C Consistently, CCL2 protein level was also significantly elevated, as measured by immunocytochemistry ( Figures S9A-S9D) . Importantly, nuclear transfer of NFkB, a signature response of LPS and Poly(I:C), can be detected as early as 0.5 hr following either treatment ( Figures S9E-S9H) , demonstrating the rapid responsiveness of pericytes. In contrast, stimulation of human brain vascular smooth muscle cells (HBVSMCs) with LPS elevated CCL2 levels much less effectively, consistent with the single-cell RNA-seq results ( Figure S6B) , although IL1b and IL6 expression increased significantly ( Figures S8F-S8H) .
To measure the effect of pericyte-secreted medium on synaptic transmission, we treated HBVP with LPS or Poly(I:C) for 2 hr, washed out the agents (to avoid confounding effects of the agents themselves), and incubated the treated HBVP with extracellular solution (ECS) for 4 hr. The pericyte-infused ECS, which contained a significant amount of CCL2 ( Figure 7A ), effectively increased mEPSC frequency and total neuronal excitability (Figures 7B-7E ). Importantly, when ECS was pre-incubated with CCL2 antibody to sequester CCL2 ( Figure 7F ), these effects were completely abolished ( Figures 7G-7J ). As control, CCL2 antibody application alone had no significant effects ( Figures  7K and 7L) . These results, together with the inability of HBVSMC to secrete CCL2, demonstrate a critical role of pericyte-secreted CCL2 in regulating excitatory synaptic transmission.
Ccl2 Knockout in PDGFRb Cells In Vivo Blocks LPS-Induced Increase in Synaptic Transmission Having shown that pericyte-secreted CCL2 was necessary and sufficient for inducing changes in excitatory synaptic transmission, we next asked whether this was also the case in vivo. Under control conditions, Ccl2 knockout (Ccl2 À/À ) mice and Pdgfrb-Cre;Ccl2 fl/fl mice have similar levels of synaptic transmission as compared with control mice (Figures S7L-S7O ). Following LPS injection, however, Ccl2 À/À mice exhibited significantly lower mEPSC frequency and reduced total neuronal excitability ( (Ctrl) and during CCL2 application (10 cells from 3 mice; Wilcoxon matched-pairs signed rank test). (P, Q, T, U, X, and Y) Representative traces (P, T, X) and summary data (Q, U, Y) of mEPSC recordings from brain regions as indicated, before and after CCL2 application (14-15 cells from 3-4 mice per condition; Wilcoxon matched-pairs signed rank test). (R, S, V, W, Z, and AA) Representative traces (R, V, Z) and summary data (S, W, AA) of firing responses to stepwise current injections, with or without CCL2 application. Brain regions as indicated (19-21 cells from 3-4 mice per condition; two-way ANOVA, Bonferroni post hoc test). See also Figure S7 . frequency, as compared to littermates ( Figures 8E and 8F) , while their total neuronal excitability exhibited a trend toward reduction ( Figures 8G and 8H ). When the latency to first spike was analyzed, significant reduction was observed in conditional knockout mice ( Figures 8I and 8J ), suggesting reduced excitability of these neurons. Consistent with the electrophysiological results, LPS-induced increase in AMPA receptor subunit GluA1 ( Figures 8K, 8L , S7P, and S7Q) was substantially attenuated in Pdgfrb-Cre;Ccl2 fl/fl mice in both the hippocampus and the cerebral cortex ( Figures 8M, 8N , S7R, and S7S).
While Ccl2 mRNA and CCL2 protein levels were significantly reduced in Pdgfrb-Cre;Ccl2 fl/fl mice following LPS injection (Figures 4D-4F) , Tnfa, Il1b, and Il6 mRNA levels were not significantly affected ( Figure 8O ), providing further evidence that CCL2 is the critical factor secreted by PDGFRb cells to regulate excitatory synaptic transmission.
PDGFRb Cells and CCL2 Mediate Early Neuroinflammatory Response in Adult Mice
The above experiments were carried out in developing mice of approximately P14. To investigate whether our observa-tions represented a general neuroinflammatory response, we repeated the key experiments in adult (P50-P60) or aged mice (older than P200). Ccl2 mRNA and CCL2 protein levels were upregulated in PDGFRb cells in both adult and aged mice 2 hr after LPS injection (Figures S10A-S10F). Importantly, CCL2 application significantly increased mEPSC frequency in adult mice (Figures S10G and S10H). The bigger brains of adult mice also allowed us to examine the time course of changes in CCL2 level in the CSF. CCL2 was significantly elevated 2 hr following LPS injection and remained elevated until 24 hr ( Figure S10I ), consistent with the high level of CCL2 reported in encephalitis patients (Kothur et al., 2016) . A significant number of white blood cells (WBC) were only detected 24 hr following LPS injection and not at the earlier 2 hr or 12 hr time point ( Figure S10J ), suggesting that the upregulation of neuronal activity by PDGFRb-secreted CCL2 occurred prior to significantly changes in BBB permeability and that infiltrating WBCs are unlikely to be the main source of CCL2 during early inflammation. Consistently, intravenous injection of Evans blue, a standard assay for measuring BBB permeability (Wang et al., 2004) , showed no significant change in the amount of Evans blue leaking to the brain (I-L) mEPSC recordings before and after CCL2 application with 10 mM U73122 in aCSF (I and J) or with 5 mM BAPTA tetracesium in the internal cellular solution (K and L), representative traces (I, K) and summary data (J, L) (9-11 cells from 3 mice; Wilcoxon matched-pairs signed rank test). See also Figure S7 . parenchyma 2 hr following LPS injection (Figures S10K and S10L). As a positive control, longer treatment consisting of injection of 1 mg/kg LPS for 3 consecutive days significantly increased the amount of leaked Evans blue (Figures S10K and S10L).
DISCUSSION
In summary, we identify Col1a1 and Rgs5 subtypes of PDGFRb cells as early sensors of infection in the brain, within 2 hr of initial insult. We further demonstrate that CCL2 secreted by PDGFRb cells functions as a neuromodulator to rapidly upregulate excitatory synaptic transmission and neuronal firing across multiple brain regions. These effects can be induced by LPS and Poly(I:C), respectively, mimicking bacterial and viral infections, suggesting that PDGFRb cells and CCL2 likely function as general sensors and mediators of neuroinflammation in the brain.
PDGFRb Cells as Early Sensors of Infection in the Brain
For cells in the brain parenchyma, it is important to be shielded as much as possible from external challenges and, at the same time, to be alerted of incoming danger as quickly as possible. By virtue of their location, cellular components of the vasculature, including endothelial cells, pericytes, vascular smooth muscle cells, perivascular macrophages, and perivascular fibroblastlike cells, are attractive candidates for early sensors. Here, we showed that within 2 hr of LPS or Poly(I:C) injection in vivo, Ccl2 colocalized with PDGFRb cells, but not with endothelial (legend continued on next page) cells (Figures 1, 2, 3, 4 , S1-S3, S5, and S6). We further used transgenic mice and single-cell RNA-seq to verify their identity (Figures 2, 3, 4, S3 , S5, and S6). Importantly, conditional knockout of Ccl2 using Pdgfrb-Cre effectively blocked LPSinduced upregulation of CCL2 expression, while Ccl2 removal from endothelial cells using Tie2-Cre had no such effects (Figures 4D and 4E) . These results clearly demonstrate that PDGFRb cells-and not endothelial cells-are the main source of Ccl2 during early neuroinflammation. They also provide the first in vivo evidence for PDGFRb cells as critical mediators of neuroinflammation.
PDGFRb cells comprise mostly pericytes and vascular smooth muscle cells. Our single-cell RNA-seq results showed that Ccl2 was most highly induced in Col1a1 and Rgs5 cell clusters, both of which express Pdgfrb, as well as a number of other previously identified pericyte markers, including Vtn, Ifitm1, and Tbx18 ( Figure 3C ). We confirmed colocalization between Vtn and Ccl2 using in situ hybridization ( Figure 4A ). Given the debate regarding the definition of pericytes (Armulik et al., 2011; Attwell et al., 2016) , we closely examined these groups. Rgs5 cells expressed a number of genes identified to be specific to pericytes in a recent single-cell RNA-seq study of the brain vasculature (Vanlandewijck et al., 2018) . On further analysis, they could be divided into Rgs5(A) cells, which highly express pericyte markers Abcc9 and Kcnj8, as well as Ccl2, and Rgs5(B) cells, which highly express the smooth muscle cell marker Acta2 and have low Ccl2 expression ( Figure S6 ). Consistently, we showed that cultured HBVP-and not HVSMC-expressed high levels of Ccl2 in response to LPS or Poly(I:C) stimulation ( Figure S8) . Thus, the subgroup of Ccl2-expressing, non-smooth muscle, Rgs5 cells fit well with cells classically defined as pericytes.
Col1a1 cells have a very similar molecular profile to perivascular fibroblast-like cells, expressing genes including Col1a1, Col1a2, Dcn, Col3a1, and Lum (Vanlandewijck et al., 2018) . Our work independently identified this cell type and, importantly, provided the first in vivo evidence of their physiological function. We showed that Col1a1 cells responded to systemic inflammation by secreting CCL2 as well as some other cytokines. As a chemokine, CCL2 not only regulates neuronal activity, it can also recruit immune cells from the periphery into the brain. In fact, we found a significant number of WBCs in the CSF 24 hr following LPS injection ( Figure S10J ). LPS-induced increase in WBCs in the CSF was significantly reduced in Ccr2 knockout mice (Varvel et al., 2016) (data not shown), suggesting a critical role of CCL2 signaling in the recruitment of WBCs to the CNS.
By identifying the Rgs5 and Col1a1 subtypes of PDGFRb cells as important early sensors of infection, we do not exclude the contribution of other cell types. Recent work showed that epithelial cells and endothelial cells responded to viral-stimulated, peripheral-secreted interferon b signaling 24 hr post infection (Blank et al., 2016) . Of the cytokines and enzymes shown to be induced along blood vessels during early infection, our dataset showed that Cxcl10, Ptgs2/Cox2, and Ptges are expressed in Col1a1 cells, Rgs5 cells, and endothelial cells. Thus, there are at least three combinations of cell-type-specific expression of cytokines and chemokines following infection: PDGFRb cells, endothelial cells, or both. Rgs5 and Col1a1 subtypes of PDGFRb cells may also separately express genes, further increasing the complexity.
Both PDGFRb and endothelial cells have access to the circulation and the brain parenchyma. However, endothelial cells, likely due to their polarized nature, have been shown to preferably release cytokines into the circulation (Quan, 2014; Verma et al., 2006) . This opens up the hypothesis that PDGFRb may primarily release factors into the brain parenchyma. Especially of interest are Col1a1-expressing perivascular fibroblast-like cells, which are located within the perivascular Virchow-Robin space and are implicated in fluid exchange between the brain and the CSF (Iliff et al., 2012; Vanlandewijck et al., 2018) . A previous study showed that removal of Ptgs2 in endothelial cells did not affect the CSF PGE 2 level (Eskilsson et al., 2017) . This could be due to high expression of Ptgs2 also in Col1a1 and Rgs5 cells. Whether its expression in Col1a1 or Rgs5 cells-or, more generally, in PDGFRb cells-is critical for entry into the CSF is a question for further investigation, with important physiological and clinical significance.
CCL2 Secreted by PDGFRb Cells Relays Neuroinflammatory Signal to Neurons
Given the close proximity between neurons and blood microvessels (8-23 mm) (Lovick et al., 1999) , perivascular cells are well suited to signal rapidly to and from neurons. Previous work has shown that that pericytes, and/or other vascular mural cells, respond to glutamate release from neurons and astrocytes to mediate activity-induced increase in local blood flow (Attwell et al., 2010; Hall et al., 2014; Hill et al., 2015; Iadecola, 2017; Peppiatt et al., 2006; Petzold and Murthy, 2011) , an important physiological response to systemic inflammation. However, it was unknown what signal elevated neuronal activity. Here we showed that PDGFRb cells secreted CCL2, which in turn rapidly upregulated excitatory synaptic transmission and total neuronal excitability in glutamatergic neurons from multiple brain regions (Figures 5, 6, 7, and S7) . The effect of CCL2 on promoting excitatory synaptic transmission is consistent with previous reports in hippocampal CA1 pyramidal neurons or spinal cord lamina II neurons (Gao et al., 2009; Zhou et al., 2011) . Importantly, we showed that LPS-induced enhancement of excitatory synaptic transmission was largely attenuated in Pdgfrb-Cre;Ccl2 fl/fl mice (Figure 8 ), suggesting that CCL2 secreted by PDGFRb cells is the main regulator of excitatory synaptic transmission during early systemic inflammation. In other words, PDGFRb cells initiate the cascade of events that lead to increased blood flow, a critical step for mounting early and effective response to external insults. 
PDGFRb Cells and Their Subtypes as Gatekeepers
Our results showed that PDGFRb cells, activated during the early phase of systemic inflammation, function as early sensors and responders of neuroinflammation. Other cells, including astrocytes and microglia, are activated later and likely remain activated for the duration of the neuroinflammatory response. Chronic, low-level activation of microglia and astrocytes, likely as a consequence of previous infection and neuroinflammation, is associated with developmental neurological disorders, including intellectual disability, epilepsy, autism spectrum disorder, and schizophrenia (Chandran et al., 2011; McAllister, 2015, 2016; Klein et al., 2017; Knuesel et al., 2014; Meyer et al., 2011; Vezzani et al., 2011; Xanthos and Sandk€ uhler, 2014) .
Effective treatment requires a balance between sufficient immune response to eliminate the infectious agents and not harming the self because of overreaction. The accessibility of PDGFRb cells (and/or Col1a1, Rgs5 subtypes) to the circulatory system and CSF and their early responsiveness, together with their ability to signal widely within the brain parenchyma, make them attractive therapeutic targets. Future studies are required to determine the relative contributions of PDGFRb cells (and/or Col1a1, Rgs5 subtypes), endothelial cells, astrocytes, microglia, and other cell types participating in the neuroinflammatory response as well as their potential therapeutic implications during early and chronic phases of disease.
Although our experiments were mostly performed in developing mice, the main findings, including LPS-induced PDGFRb cells expression of CCL2 and the ability of CCL2 to upregulate excitatory synaptic transmission, also occurred in adult and aging mice ( Figure S10 ). These results suggest that the ability of PDGFRb cells to sense and relay the inflammatory response is a general physiological response that occurs throughout the lifetime of the organism.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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STAR+METHODS KEY RESOURCES
Whole-Cell Recordings
For recordings, individual slices were transferred to a submersion recording chamber and were continuously perfused with 95% O 2 /5% CO 2 bubbled with aCSF at 28-30 C. Slices were visualized with an upright microscope (BX51WI, Olympus, Tokyo, Japan) equipped with differential interference contrast optics and an infrared CCD camera (IR-1000E, DAGE-MTI, Michigan, IN, USA). Recordings were made from neurons in hippocampal CA1, CA3, dentate gyrus, or cortical primary somatosensory areas (S1), with a MultiClamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA). Signals were low-pass filtered at 2 kHz and sampled at 10 kHz using Digidata 1440A (Molecular Devices). For mEPSC recordings, glass pipettes (resistance, 3-5 MU) were loaded with internal solution containing (in mM): 100 CsMeSO 4 , 25.5 CsCl, 10 HEPES, 8 NaCl, 0.25 EGTA, 10 D-glucose, 2 MgATP and 0.3 Na 3 GTP (pH 7.3, 290 mOsm), and all neurons were held at À70 mV in voltage-clamp mode; 10 mM gabazine and 1 mM TTX were added to aCSF to block GABA A and Na + currents, respectively. BAPTA tetracesium (5 mM) was added to the internal solution to block Ca 2+ -induced effects.
For mIPSC recordings, a high chloride internal solution containing (in mM): 110 CsCl, 10 NaCl, 5 MgCl 2 , 0.6 EGTA, 2 MgATP, 0.2 Na 3 GTP and 40 HEPES (pH 7.3, 290 mOsm) was used, and cells were held at À60 mV in voltage-clamp mode; 10 mM NBQX and 1 mM TTX were added to block AMPA and Na + currents, respectively.
For all mPSC recordings, a brief hyper-polarization step (À10 mV, 100 ms) was given to monitor series and input resistances every 10 s. Cells were excluded from analysis if their input resistance fluctuated by more than 20% or if series resistance exceeded 30 MU. Series resistances were not significantly different between experimental groups. Liquid junction potential and series resistance were uncompensated.
The spike frequency versus injected current experiments were performed by measuring the average action potential firing rate during 500 ms depolarizing current injections of 20 pA increments (10 pA for dentate gyrus), in current-clamp mode. The maximum current injected in each experiment was below the current that induced adaptation. The first step current which induced a spike was defined as the rheobase current. Synaptic blockers (50 mM D-APV, 10 mM NBQX, and 10 mM gabazine) were included as indicated. The internal solution contained (in mM): 110 K-gluconate, 20 KCl, 20 HEPES, 5 MgCl 2 , 0.6 EGTA, 2 MgATP, 0.2 Na 3 GTP (pH 7.3, 290 mOsm).
Evoked EPSC, AMPA/NMDA ratio and paired-pulse ratio were recorded in aCSF containing 10 mM gabazine. A glass pipette filled with aCSF was placed in the stratum radiatum, and generated a brief stimulation pulse (1 ms) under the control of Digidata 1440A (Molecular Devices) and Iso-Flex isolator (A.M.P.I., Jerusalem, Israel). Minimal evoked EPSC was recorded at a stimulation strength which induced both EPSCs and failures, with a failure rate of approximately 50%. AMPA receptor and NMDA receptor-mediated EPSCs of hippocampal CA1 pyramidal neurons were recorded at holding potentials of -70 mV and +40 mV, respectively. AMPA receptor-dependent EPSCs were quantified by measuring the peak amplitude after the onset of synaptic responses, while NMDA receptor-dependent EPSC amplitudes were measured 50 ms after EPSC onset, as previously described (Peng et al., 2010) . Paired-pulse ratio (PPR) was measured as the ratio of the second EPSC to the first one.
In CCL2 application experiment, CCL2 was perfused onto slices at 100 ng/ml, based on previous investigations in other systems (Gao et al., 2009; Gosselin et al., 2005) . In CCL2 mPSC experiments, baseline (Ctrl) recordings were from 0 -5 min before CCL2 application, while CCL2 recordings were from 5 -10 min after CCL2 perfusion. For all other experiments, recordings from Ctrl and experimental conditions were interleaved. To investigate the effect of stimulated HBVP ECS, brain slices were incubated with HBVP-conditioned Ctrl ECS, LPS/Poly(I:C) stimulated ECS or antibody neutralized ECS for 30 min at 26 C before recordings. LPS/Poly(I:C) were washed out from the stimulated ECS (see ECS collection section for details).
All salts and drugs were obtained from Sigma or Tocris Bioscience, except for TTX, which was obtained from the Fisheries Science and Technology Development Company of Hebei Province, China.
Data were analyzed in Clampfit 9 (Molecular Devices), except for the amplitude and frequency of mPSCs, which were analyzed in MiniAnalysis (Synaptosoft, Fort Lee, NJ, USA) with detection thresholds of 5 pA. The total charge per second was calculated by summing the area of each mPSC event, per unit time. Data analysis was carried out blinded to the experimental condition.
Single-Cell RNA Sequencing and Data Processing Three independent sets of experiments were carried out. In each experiment, P14 mice were i.p. injected with saline (control) or 10 mg/kg LPS, and sacrificed 2 hr later. Acute brain slices were prepared as for electrophysiological experiments (see above for details). Each sample contained brain slices from one male and one female mouse, to reduce batch effects. After the brain slices recovered, hippocampi were dissected and dissociated using the Papain Dissociation System (Worthington, Lakewood, NJ, USA; Cat# LK003153) according to the manufacturer's instructions. The cell suspension was filtered with a 40 mm filter (Thermo Fisher Scientific, Cat# 352340) and resuspended in DMEM (Thermo Fisher Scientific, Cat# 12800017) containing 10% Fetal Bovine Serum (Thermo Fisher Scientific, Cat# C838T52) Single cells were captured using the 10X Chromium (10X Genomics, Pleasanton, CA, USA), and
